Clear Street Launches Healthcare & Biotechnology Equity Research

BusinesswireDec 18 03:00

We're Hopeful That Enliven Therapeutics (NASDAQ:ELVN) Will Use Its Cash Wisely

Simply Wall StDec 14 22:13

BTIG Initiates Enliven Therapeutics(ELVN.US) With Buy Rating, Announces Target Price $42

Futu NewsDec 13 19:31 · Ratings

Enliven Therapeutics' ELVN-001: Navigating Competitive Challenges and Opportunities in the CML Market

TipRanksDec 11 02:55

LifeSci Capital Maintains Enliven Therapeutics(ELVN.US) With Buy Rating, Maintains Target Price $38

Futu NewsDec 9 21:31 · Ratings

JonesTrading Maintains Enliven Therapeutics(ELVN.US) With Buy Rating, Maintains Target Price $36

Futu NewsDec 6 00:35 · Ratings